Ruby C.Y. Lin

6.5k total citations · 2 hit papers
79 papers, 4.8k citations indexed

About

Ruby C.Y. Lin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Ruby C.Y. Lin has authored 79 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Epidemiology. Recurrent topics in Ruby C.Y. Lin's work include MicroRNA in disease regulation (16 papers), Bacteriophages and microbial interactions (12 papers) and Adipose Tissue and Metabolism (9 papers). Ruby C.Y. Lin is often cited by papers focused on MicroRNA in disease regulation (16 papers), Bacteriophages and microbial interactions (12 papers) and Adipose Tissue and Metabolism (9 papers). Ruby C.Y. Lin collaborates with scholars based in Australia, United States and Switzerland. Ruby C.Y. Lin's co-authors include Margaret J. Morris, Julie A. Owens, D. Ross Laybutt, Romain Barrès, Julie R. McMullen, Bianca C. Bernardo, Brian J. Morris, Ian W. Dawes, Jenny Y. Y. Ooi and Benjamin Tang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ruby C.Y. Lin

76 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring

2010 971 citations Ruby C.Y. Lin, Margaret J. Morris et al. profile →
Safety of bacteriophage therapy in severe Staphylococcus aureus infection

2020 331 citations Aleksandra Petrović Fabijan, Ruby C.Y. Lin et al. Nature Microbiology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ruby C.Y. Lin	2.3k	844	652	603	556	79	4.8k
Julio Sotelo	1.7k 0.7×	457 0.5×	244 0.4×	1.1k 1.8×	267 0.5×	214	7.4k
Ying-Tsong Chen	3.2k 1.4×	268 0.3×	522 0.8×	1.1k 1.8×	2.2k 4.0×	60	8.3k
Jeremy B. M. Jowett	2.5k 1.1×	551 0.7×	169 0.3×	1.7k 2.8×	1.1k 2.0×	70	6.3k
Eric K. Moses	1.2k 0.5×	418 0.5×	949 1.5×	450 0.7×	301 0.5×	162	4.2k
Shuai Wang	1.8k 0.8×	631 0.7×	234 0.4×	659 1.1×	213 0.4×	277	5.1k
Wenjing Wang	2.5k 1.1×	813 1.0×	337 0.5×	508 0.8×	261 0.5×	290	5.1k
Na Wang	2.1k 0.9×	454 0.5×	161 0.2×	605 1.0×	545 1.0×	273	5.0k
Peter Kopp	2.5k 1.1×	389 0.5×	372 0.6×	410 0.7×	594 1.1×	225	7.7k
Gregory A. Hawkins	2.1k 0.9×	641 0.8×	168 0.3×	328 0.5×	1.7k 3.0×	123	6.3k
Daniel Sinnett	3.7k 1.6×	1.0k 1.2×	1.7k 2.6×	598 1.0×	492 0.9×	296	8.8k

Countries citing papers authored by Ruby C.Y. Lin

Since Specialization

Citations

This map shows the geographic impact of Ruby C.Y. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby C.Y. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby C.Y. Lin more than expected).

Fields of papers citing papers by Ruby C.Y. Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby C.Y. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby C.Y. Lin. The network helps show where Ruby C.Y. Lin may publish in the future.

Co-authorship network of co-authors of Ruby C.Y. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby C.Y. Lin. A scholar is included among the top collaborators of Ruby C.Y. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby C.Y. Lin. Ruby C.Y. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lynch, Stephanie, et al.. (2025). Policy in practice: Cystic Fibrosis Australia and Phage Australia surveys: understanding clinical needs and attitudes towards phage therapy in the cystic fibrosis community. 2(1).

Lynch, Stephanie, et al.. (2025). Attitudes to phage therapy among Australian infectious diseases physicians. International Journal of Antimicrobial Agents. 66(5). 107579–107579.

Lee, Shinwon, Stephanie Lynch, Ruby C.Y. Lin, Heejoon Myung, & Jonathan R. Iredell. (2023). Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection and Chemotherapy. 56(1). 57–57. 4 indexed citations

Lin, Ruby C.Y., et al.. (2023). Placental Histopathologic Findings of a Large Cohort of Patients With SARS-CoV-2 Infection During Pregnancy. International Journal of Gynecological Pathology. 42(6). 589–596. 3 indexed citations

Lin, Ruby C.Y., et al.. (2023). Cesarean scar ectopic pregnancy: nuances in diagnosis and treatment. Fertility and Sterility. 120(3). 563–572. 7 indexed citations

Narayanan, Ramesh K., Kaitao Lai, Melina Ellis, et al.. (2022). Novel gene–intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy. Brain. 146(3). 880–897. 9 indexed citations

Khatami, Ameneh, David A. Foley, Morgyn S. Warner, et al.. (2022). Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial. BMJ Open. 12(12). e065401–e065401. 41 indexed citations

Lin, Ruby C.Y., et al.. (2022). Two plus One: Combination Therapy Tri-systems Involving Two Membrane-Disrupting Antimicrobial Macromolecules and Antibiotics. ACS Infectious Diseases. 8(8). 1480–1490. 11 indexed citations

Lin, Ruby C.Y., Yun‐Yi Hung, Julia N. Cheng, & Elizabeth Suh‐Burgmann. (2022). Accuracy of Magnetic Resonance Imaging for Identifying Ovarian Cancer in a Community-Based Setting. Women s Health Reports. 3(1). 43–48. 1 indexed citations

10.

Sacher, Jessica, et al.. (2022). Data to Power Precision Phage Therapy: A Look at the Phage Directory–Phage Australia Partnership. PubMed Central. 3(2). 112–115. 4 indexed citations

11.

Lin, Ruby C.Y., et al.. (2021). Phage Biobank: Present Challenges and Future Perspectives. Current Opinion in Biotechnology. 68. 221–230. 30 indexed citations

12.

Khatami, Ameneh, Ruby C.Y. Lin, Aleksandra Petrović Fabijan, et al.. (2021). Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO Molecular Medicine. 13(9). e13936–e13936. 51 indexed citations

13.

Fabijan, Aleksandra Petrović, Ruby C.Y. Lin, Josephine Ho, et al.. (2020). Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nature Microbiology. 5(3). 465–472. 331 indexed citations breakdown →

14.

Cartland, Siân P., Gonzalo J. Martínez, S. E. J. Robertson, et al.. (2019). TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis. iScience. 12. 41–52. 38 indexed citations

15.

Lin, Ruby C.Y., Glen Reid, Luciano Mutti, et al.. (2017). P1.05-021 circRNAs: Potential Novel Biomarkers for the Early Detection of Lung Cancer. Journal of Thoracic Oncology. 12(1). S626–S627. 2 indexed citations

16.

Bernardo, Bianca C., Jenny Y. Y. Ooi, Aya Matsumoto, et al.. (2016). Sex differences in response to miRNA‐34a therapy in mouse models of cardiac disease: identification of sex‐, disease‐ and treatment‐regulated miRNAs. The Journal of Physiology. 594(20). 5959–5974. 38 indexed citations

17.

Lin, Ruby C.Y., et al.. (2014). Gene expression in rat models for inter-generational transmission of islet dysfunction and obesity. Genomics Data. 2. 351–353. 3 indexed citations

18.

Kirschner, Michaela B., Yuen Yee Cheng, Nicola J. Armstrong, et al.. (2014). MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology. 9(3). 715–726. 56 indexed citations

19.

Chung, Henry, Ruby C.Y. Lin, Grant J. Logan, et al.. (2011). Human Induced Pluripotent Stem Cells Derived Under Feeder-Free Conditions Display Unique Cell Cycle and DNA Replication Gene Profiles. Stem Cells and Development. 21(2). 206–216. 20 indexed citations

20.

Pretorius, Lynette, Xiao‐Jun Du, Elizabeth A. Woodcock, et al.. (2009). Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation. American Journal Of Pathology. 175(3). 998–1009. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact